Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
12
users have liked this narrative
8
users have commented on this narrative
49
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
2
users have commented on this narrative
17
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
PNC Infratech
AN
AnalystConsensusTarget
Consensus Narrative from 16 Analysts
Upcoming NHAI Projects Will Provide Opportunities, But Delays And Financial Strains May Pose Challenges
Key Takeaways Expedited project awards and substantial budget allocation could significantly bolster revenue through increased order inflows and project participation. Implementation of advanced construction technologies alongside asset divestment can improve margins and strengthen future earnings.
View narrative
₹387.94
FV
20.5% undervalued
intrinsic discount
9.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
4 days ago
author updated this narrative
Paragon Banking Group
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Commercial Lending Shift And Tech Investments Will Improve Operational Efficiency
Key Takeaways Strategic investment in technology and AI aims to enhance efficiency and customer experience, driving improved net margins and earnings growth. Shifting focus to higher-margin commercial lending and robust loan growth supports future revenue and net interest margin expansion.
View narrative
UK£9.92
FV
8.4% undervalued
intrinsic discount
2.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
4 days ago
author updated this narrative
IGG
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Frozen War And Tycoon Master Will Drive Future Markets
Key Takeaways Strong synergies in the APP business, coupled with new game launches, present robust revenue and user engagement potential, enhancing profitability prospects. Strategic use of AI for cost reduction and focused financial policies like share buybacks could attract investors and drive efficient growth.
View narrative
HK$4.75
FV
0.9% overvalued
intrinsic discount
1.42%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
C-Rad
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Aging Population And Healthcare Digitization Will Expand Radiotherapy Demand
Key Takeaways Rising global demand for radiotherapy and healthcare digitization position C-Rad for long-term growth, higher margins, and expanded market presence. Increased recurring service revenues and operational efficiencies are enhancing profit stability and buffering earnings against short-term fluctuations.
View narrative
SEK 39.00
FV
14.1% undervalued
intrinsic discount
13.08%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
4 days ago
author updated this narrative
K+S
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Global Demand Will Transform The Potash Fertilizer Sector
Key Takeaways Rising global food demand and tight supply support stable revenue growth and margin improvement for the company's core fertilizer products. Strategic investments and effective cost control initiatives position the company for greater earnings stability and resilience against industry volatility.
View narrative
€15.16
FV
16.8% undervalued
intrinsic discount
2.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
4 days ago
author updated this narrative
Australian Clinical Labs
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
AI And New Genetic Tests Will Drive Future Operational Improvements
Key Takeaways Expansion into genetic molecular testing and operational efficiency initiatives are set to bolster revenue growth and enhance net margins. Strategic acquisitions domestically and internationally offer accelerated growth potential by expanding market share and leveraging synergies.
View narrative
AU$3.72
FV
27.6% undervalued
intrinsic discount
4.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
4 days ago
author updated this narrative
Acerinox
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Tariff Clarity And Sustainable Demand Will Shape Stainless Steel Future
Key Takeaways Delayed global infrastructure and trade clarity are currently suppressing demand, but pent-up restocking and sector recovery are expected to drive revenue and earnings rebound. A focus on sustainable products, specialty alloys, and production efficiency better positions Acerinox for margin expansion, top-line growth, and long-term competitiveness.
View narrative
€13.04
FV
17.8% undervalued
intrinsic discount
8.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
4 days ago
author updated this narrative
CSL
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Advancements In iNOMi Technology And HEMGENIX Will Strengthen Market Position
Key Takeaways Advancements in plasma collection and operational efficiencies are set to reduce costs and improve CSL Behring's margins, potentially boosting overall earnings. Product rollouts and expanded market approvals, especially in HAE therapy, aim to drive revenue growth and offset vaccine sector challenges.
View narrative
AU$311.00
FV
13.1% undervalued
intrinsic discount
6.83%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
111
users have followed this narrative
4 days ago
author updated this narrative
74SW
74Software
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Cloud Shift Will Open New Digital Markets
Key Takeaways Growing adoption of cloud-based, AI-driven SaaS solutions and successful cross-selling are fueling robust topline growth and expanding market opportunities. Operational efficiencies, improved profitability, and strong cash flow position the company for accretive acquisitions and premium valuation through inorganic growth.
View narrative
€49.47
FV
22.0% undervalued
intrinsic discount
4.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies